Top 15 Biotech Venture Capital Deals of 2010

Fierce Biotech has put together a list of top biotech investments from last year: 

Last year biotech venture capital investing began to recover from its 2009 low, growing three percent in the number of dollars raised and eight percent in the number of deals which were struck. That represents a significant bounce-back from 2009, which saw biotech investing plummet 19 percent during the worst of the economic crisis...

1. Pacific Biosciences - $109M
2. Reata Pharmaceuticals - $78M
3. Relypsa - $70M
More after the jump:

4. Pearl Therapeutics - $69M
5. NanoInk - $65M
6. TetraLogic Pharmaceuticals - $59.83
7. Achaogen - $56.31M
8. Otonomy - $49.07M
9. Tetraphase Pharmaceuticals - $45M
10. Agile Therapeutics - $45M
11. Incline Therapeutics - $43M
12. Cellular Dynamics International - $40.6M
13. Calistoga Pharmaceuticals - $40.22M
14. Sagent Pharmaceuticals - $40M
15. Complete Genomics - $39M
16. Intrexon - $37.51M